Clinical Trial

Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

Name: Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers — clinical trial record (NCT07349758)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DD-PrEP:

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate the pharmacokinetics of a one-time dosing of two F/TAF tablets over a 14-day period.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-15.

Trial Details

NCT Number	NCT07349758
Lead Sponsor	Johns Hopkins University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Healthy Volunteer, HIV Prevention
Enrollment	24 participants
Start Date	2026-01-06
Primary Completion	2027-01-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-13